DiaMedica Therapeutics to Present Research at National Kidney Foundation 2020 Spring Clinical Meetings Live Virtual Conference Mar 26, 2020 09:12AM
DiaMedica Therapeutics Inc. (DMAC) Reports First Patient Dosed in REDUX Phase II Clinical Trial of DM199 Dec 17, 2019 04:15PM
DiaMedica Therapeutics Announces First Patient Dosed in REDUX Phase II Clinical Trial of DM199 for the Treatment of Chronic Kidney Disease Dec 17, 2019 04:14PM
DiaMedica Therapeutics to Report Third Quarter 2019 Financials and Provide a Business Update November 14, 2019 Nov 6, 2019 04:04PM
DiaMedica Therapeutics Inc. (DMAC) Announces Clearance to Initiate Phase II Clinical Trial of DM199 for CKD Oct 14, 2019 07:48AM


Oct 14, 2019 07:42AM DiaMedica Therapeutics Announces Clearance to Initiate Phase II Clinical Trial of DM199 for Chronic Kidney Disease
Sep 6, 2019 09:00AM DiaMedica Therapeutics to Present at Lake Street’s 3rd Annual Best Ideas Growth (BIG3) Conference on September 12, 2019
Aug 8, 2019 04:00PM DiaMedica Therapeutics to Report Second Quarter 2019 Financials and Provide a Business Update August 13, 2019
Jun 19, 2019 04:12PM DiaMedica Therapeutics Inc. (DMAC) Reports Interim Results from Phase 1b Trial of DM199 in Chronic Kidney Disease Participants
Jun 19, 2019 04:04PM DiaMedica Therapeutics Announces Interim Results from Phase 1b Trial of DM199 in Chronic Kidney Disease Participants
May 6, 2019 08:54AM DiaMedica Therapeutics to Report First Quarter 2019 Financials and Provide an Update on Development Programs on May 14, 2019
Apr 30, 2019 04:58PM DiaMedica Therapeutics to Present at CKD3 Kidney Summit Meeting
Feb 14, 2019 08:00AM DiaMedica Therapeutics Doses First Patient in Phase 1b Clinical Study of DM199 in Patients with Chronic Kidney Disease
Jan 22, 2019 07:45AM DiaMedica Therapeutics Announces Publication of a Paper, “Human Tissue Kallikrein in the Treatment of Acute Ischemic Stroke,” in the Journal Therapeutic Advances in Neurological Disorders
Jan 3, 2019 10:41AM UPDATE -- DiaMedica Announces FDA Clearance of IND Application To Study DM199 in Patients with Chronic Kidney Disease
Jan 3, 2019 07:30AM DiaMedica Announces FDA Clearance of IND Application To Study DM199 in Patients with Chronic Kidney Disease